معرفی
Kevin Taddei is a Researcher in Neuroscience at Edith Cowan University's School of Medical and Health Sciences. He holds a Bachelor of Science from Curtin University (1994). His work focuses on Alzheimer's disease biomarkers, neurodegenerative processes, and lifestyle factors influencing cognitive health. Key research areas include blood-based biomarkers, sleep quality, diet, and physical activity's impact on amyloid accumulation and cognitive decline.
Research highlights include studies on plasma pTau217 for Alzheimer's staging, APOE ε2 genetic resilience, and coffee consumption's protective effects. He has contributed to large cohort studies like the Australian Imaging, Biomarkers and Lifestyle Study (AIBL) and the Dominantly Inherited Alzheimer Network. Funding includes significant grants from the Australian Alzheimer's Research Foundation and the Lions Alzheimer's Foundation, totaling over $8 million.
His work integrates neuroimaging (e.g., PET), proteomics, and longitudinal tracking to advance early detection and prevention strategies. Collaborations span global networks like the FINGER prevention trials. Ongoing projects explore retinal imaging as a non-invasive Alzheimer's biomarker and multidomain lifestyle interventions (AU-ARROW study).
